Dysplasia and tumor discrimination in brain tissues by combined fluorescence, Raman, and diffuse reflectance spectroscopies.
Enrico BariaFlavio GiordanoRenzo GuerriniChiara CaporaliniAnna Maria BuccolieroRiccardo CicchiFrancesco Saverio PavonePublished in: Biomedical optics express (2023)
Identification of neoplastic and dysplastic brain tissues is of paramount importance for improving the outcomes of neurosurgical procedures. This study explores the combined application of fluorescence, Raman and diffuse reflectance spectroscopies for the detection and classification of brain tumor and cortical dysplasia with a label-free modality. Multivariate analysis was performed to evaluate classification accuracies of these techniques-employed both in individual and multimodal configuration-obtaining high sensitivity and specificity. In particular, the proposed multimodal approach allowed discriminating tumor/dysplastic tissues against control tissue with 91%/86% sensitivity and 100%/100% specificity, respectively, whereas tumor from dysplastic tissues were discriminated with 89% sensitivity and 86% specificity. Hence, multimodal optical spectroscopy allows reliably differentiating these pathologies using a non-invasive, label-free approach that is faster than the gold standard technique and does not require any tissue processing, offering the potential for the clinical translation of the technology.
Keyphrases
- label free
- gene expression
- single molecule
- machine learning
- pain management
- deep learning
- high resolution
- white matter
- low grade
- resting state
- magnetic resonance imaging
- cerebral ischemia
- multiple sclerosis
- magnetic resonance
- structural basis
- skeletal muscle
- high speed
- human health
- blood brain barrier
- high grade
- weight loss